KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to 1.26.

  • Rigel Pharmaceuticals' Asset Utilization Ratio rose 678.35% to 1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.26, marking a year-over-year increase of 678.35%. This contributed to the annual value of 1.28 for FY2024, which is 3718.52% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Asset Utilization Ratio stood at 1.26, which was up 678.35% from 1.4 recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Asset Utilization Ratio peaked at 1.4 during Q2 2025, and registered a low of 0.54 during Q1 2022.
  • In the last 5 years, Rigel Pharmaceuticals' Asset Utilization Ratio had a median value of 1.0 in 2023 and averaged 0.97.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 3454.51% in 2022, then surged by 8713.38% in 2023.
  • Over the past 5 years, Rigel Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.84 in 2021, then increased by 14.09% to 0.96 in 2022, then grew by 4.45% to 1.01 in 2023, then grew by 17.57% to 1.18 in 2024, then rose by 6.25% to 1.26 in 2025.
  • Its Asset Utilization Ratio was 1.26 in Q3 2025, compared to 1.4 in Q2 2025 and 1.19 in Q1 2025.